Masashi Okada
Yamagata University
H-index: 32
Asia-Japan
Top articles of Masashi Okada
Antagonizing MDM2 overexpression induced by MDM4 inhibitor CEP-1347 effectively reactivates wild-type p53 in malignant brain tumor cells
Cancers
2023/8/30
Masashi Okada
H-Index: 21
The Novel MDM4 Inhibitor CEP-1347 Activates the p53 Pathway and Blocks Malignant Meningioma Growth In Vitro and In Vivo
Biomedicines
2023/7/12
Masashi Okada
H-Index: 21
Domatinostat Targets the FOXM1–Survivin Axis to Reduce the Viability of Ovarian Cancer Cells Alone and in Combination with Chemotherapeutic Agents
International Journal of Molecular Sciences
2023/6/28
Masashi Okada
H-Index: 21
Givinostat inhibition of sp1-dependent MGMT expression sensitizes glioma stem cells to temozolomide
Anticancer Research
2023/3/1
Masashi Okada
H-Index: 21
HDAC class I inhibitor domatinostat preferentially targets glioma stem cells over their differentiated progeny
International Journal of Molecular Sciences
2022/7/22
Masashi Okada
H-Index: 21
Gemcitabine cooperates with everolimus to inhibit the growth of and sensitize malignant meningioma cells to apoptosis induced by navitoclax, an inhibitor of anti-apoptotic bcl …
Cancers
2022/3/27
Masashi Okada
H-Index: 21
CEP-1347 targets MDM4 protein expression to activate p53 and inhibit the growth of glioma cells
Anticancer Research
2022/10/1
Masashi Okada
H-Index: 21
Inhibition of the Phospholipase Cε–c-Jun N-Terminal Kinase Axis Suppresses Glioma Stem Cell Properties
International Journal of Molecular Sciences
2022/8/7
Masashi Okada
H-Index: 21
Targeting folate metabolism is selectively cytotoxic to glioma stem cells and effectively cooperates with differentiation therapy to eliminate tumor-initiating cells in glioma …
International Journal of Molecular Sciences
2021/10/27
Masashi Okada
H-Index: 21
Lurasidone sensitizes cancer cells to osimertinib by inducing autophagy and reduction of survivin
Anticancer Research
2021/9/1
Masashi Okada
H-Index: 21
Dexamethasone sensitizes cancer stem cells to gemcitabine and 5-fluorouracil by increasing reactive oxygen species production through nrf2 reduction
Life
2021/8/27
Masashi Okada
H-Index: 21
Inhibition of the Lipid Droplet–Peroxisome Proliferator-Activated Receptor α Axis Suppresses Cancer Stem Cell Properties
Genes
2021/1/14
Masashi Okada
H-Index: 21
Inhibition of the lipid dropletperoxisome proliferator-activated receptor α axis suppresses cancer stem cell properties. Genes. 2021; 12: 99
2021
Gemcitabine radiosensitization primes irradiated malignant meningioma cells for senolytic elimination by navitoclax
Neuro-Oncology Advances
2021/1/1
Atsushi Sato
H-Index: 12
Masashi Okada
H-Index: 21
Therapeutic targeting of pancreatic cancer stem cells by dexamethasone modulation of the MKP-1–JNK axis
Journal of Biological Chemistry
2020/12/25
Masashi Okada
H-Index: 21
Atsushi Sato
H-Index: 12
Inhibition of retinoblastoma cell growth by CEP1347 through activation of the P53 pathway
Anticancer Research
2020/9/1
Masashi Okada
H-Index: 21
Doxazosin, a classic alpha 1-adrenoceptor antagonist, overcomes osimertinib resistance in cancer cells via the upregulation of autophagy as drug repurposing
Biomedicines
2020/8/5
Masashi Okada
H-Index: 21
Verteporfin inhibits oxidative phosphorylation and induces cell death specifically in glioma stem cells
The FEBS Journal
2020/5
Masashi Okada
H-Index: 21
